Katherine E Eddy,Joshua P Vogel,Nick Scott,Dagnachew Fetene,Tom Tidhar,Olufemi T Oladapo,Gilda Piaggio,My Huong Nguyen,Fernando Althabe,Rajiv Bahl,Suman P N Rao,Ayesha De Costa,Suchita Gupta,Abdullah H. Baqui,Mohammod Shahidullah,Saleha Begum Chowdhury,Salahuddin Ahmed,Saima Sultana,Iffat Ara Jaben,Shivaprasad S Goudar,Sangappa M Dhaded,Yeshita V Pujar,Sunil S Vernekar,Saraswati Welling,Geetanjali M Katageri,Muttappa R Gudadinni,Saumya Nanda,Zahida Qureshi,Harriet Tunu Baraka,Alfred Osoti,George Gwako,John Kinuthia,Samuel Ojo,Adesina Olubukola Adeponle,Ayede Adejumoke Idowu,Ebunoluwa Aderonke Adejuyigbe,Oluwafemi Kuti,Bankole Peter Kuti,Francis Bola Akinkunmi,Weyinmi Emmanuel Kubeyinje,Hadijat Olaide Raji,Olusanya Abiodun,Anthony Dennis Isah,Shabina Ariff,Sajid Bashir Soofi,Lumaan Sheikh,Almas Aamir and Farrukh Raza. Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial. Lancet Glob Health. 2022;10(10):10.1016/s2214-109x(22)00340-0.
